Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
|Videos|March 21, 2022
What to look forward to at NAPNAP 2022
Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN, shares why she's excited for NAPNAP 2022 and what her "can't miss" sessions are.
Advertisement
Jessica L. Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN, a clinical professor at the Baylor University Louise Herrington School of Nursing sits down with Contemporary Pediatrics to discuss why she's excited for NAPNAP 2022 and what her "can't miss" sessions for the conference are.
Advertisement
Related to this article
A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
In 5.2 million US infants, newborn vitamin K nonreceipt rose to 6.8% by 2025 and was tied to a 47% higher bleeding risk by 6 months.
New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.
Jessica Nash, MD, IBCLC, shares strategies for assessing breastfeeding, identifying latch problems, and connecting families with lactation resources.
Find out the 4 FDA decisions to watch in November 2026 for pediatric care.
Michael Pistiner, MD, discusses how pediatricians can support food allergy management in schools through accurate diagnosis, emergency plans, and education.
Cenobamate sNDAs target PGTC seizures in patients ≥12 years and pediatric focal seizures; phase 3 PGTC data showed a 71.9% median reduction.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Skipping newborn vitamin K tied to 47% higher infant bleeding risk
2
Breastfeeding essentials: Assessing latch and milk transfer
3
Study identifies gaps in infant RSV immunization timing
4
Contemporary Pediatrics week in review: November 2-6, 2026
5